Clinical Trial Update: Ciprofloxacin on Burned Patients [Phase 3]

View source ↗

Summary

A Bayer-sponsored Phase 3 trial evaluating ciprofloxacin for bacterial infections in burn patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections
• Burns

Drugs mentioned

• Ciprofloxacin (Ciprofloxacin hydrochloride)

Snippet

Sponsor: Bayer | Conditions: Burns, Bacterial Infections | Phase 3 | Status: COMPLETED